Skip to main content
Logo

Jean Marie Vianney Habarugira

Dr. Jean Marie Vianney Habarugira joined the Global Health EDCTP3 in March 2023. He is the Senior Scientific Officer and Acting Head of the Scientific Operations Unit, where he provides strategic, scientific and operational leadership in the implementation of major international clinical research studies targeting infectious diseases.

With more than 15 years of experience across all three EDCTP programmes (under the European Union Framework Programmes FP6, FP7, Horizon 2020 and Horizon Europe), he has played a key role in shaping and advancing the European-African research and innovation agenda. His responsibilities include overseeing large-scale multinational clinical research projects, coordinating the activities of the Scientific Committee, and contributing to the strategic development and implementation of the organisation's scientific priorities.

A trained pharmacist holding a PhD in Pharmacology and an MSc in Pharmacovigilance and Pharmacoepidemiology, Dr. Habarugira brings extensive expertise in drug development, clinical research, pharmacovigilance and medicines safety. His scientific and professional work has focused on accelerating the development and evaluation of interventions for infectious and neglected diseases, with particular emphasis on improving health outcomes and strengthening research capacity across sub-Saharan Africa.

Beyond his institutional responsibilities, Dr. Habarugira serves on the Executive Board of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), contributing to international efforts to strengthen research preparedness and accelerate coordinated research responses to emerging infectious disease threats. He is also actively engaged in international scientific networks and working groups promoting research coordination, rapid mobilisation of research capabilities, data sharing and equitable collaboration during public health emergencies.

A regular contributor to high-level international scientific fora and policy discussions, he advocates for sustainable clinical trial capacity, stronger research infrastructures, African scientific leadership and equitable, long-term partnerships between Europe and Africa.

Throughout his career, Dr. Habarugira has remained committed to advancing inclusive, resilient and locally driven research ecosystems, ensuring that scientific innovation translates into meaningful health impact and strengthens global preparedness for current and future health challenges.

Linkedin